National Pharmaceutical Pricing Authority (NPPA) is an organization of the Government of India which is an executive body under the Drugs (Prices Control) Order (DPCO), 2013 established to fix/ revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country. There are some key announcements/notice released by NPPA for the month of December 2017 as described below -
- National List of Essential Medicines (NLEM), 2015 formulations under provisions of DPCO, 2013 (Consolidated list as on 30.11.2017)
- NPPA fixed/revised ceiling prices/Retail Prices of 65 scheduled formulations under DPCO, 2013
- Form -I application for price fixation of new drug under Para 2(u) of DPCO, 2013
- NPPA fixed/revised ceiling prices/Retail Prices of 27 scheduled formulations under DPCO, 2013
- NPPA's consideration of Medtronic's request for discontinuation of Endeavour Sprint RX Zotarolimus Eluting Coronary Stent System
National List of Essential Medicines (NLEM), 2015 formulations pending for price fixation
On December 06, 2017, NPPA released the list of formulations pending for ceiling price fixations as on November 2017 under NLEM 2015, as the All Indian Origin Chemists & Distributors (AIOCD) association's Pharmatrac is not capturing the Price to Retailer (PTR) and Moving Annual Turnover (MAT) of said formulations. Therefore, NPPA requested all the concerned manufacturers / marketing companies to furnish the PTR & MAT in terms of value, duly self-attested with proper authorized signature & seal of the authorized officer of the company, for the formulations listed in NLEM, 2015 (revised Schedule - I of DPCO, 2013) i.e. Annexure -I for the month of August 2015 by December 22, 2017 for enabling NPPA to take appropriate action for ceiling price fixation under provisions of DPCO, 201327.
NPPA has fixed/revised ceiling prices/Retail Prices of 65 scheduled formulations under DPCO, 2013
On December 18, 2017, the NPPA has fixed/revised the ceiling /retail prices of 65 scheduled formulations under DPCO. The 65 scheduled formulations under price cap are mostly from anti-cancer, anti-HIV, anti-diabetics, lipid lowering drugs and other antibiotics categories as described below under various provisions -
Table1-Notified Retail price of 63 formulations under Drugs (Prices Control) Order, 2013
| S l . No. | Name of the Scheduled Formulation / Brand Name | Strength | Unit |
| 1. | Ferrous Ascorbate + Folic Acid + Cyanocobalamin +Zinc Sulphate Monohydrate tablet (Autrin - XT) | Ferrous Ascorbate eq. to Elemental Iron 100mg, Folic Acid IP 1.5mg, Cyanocobalamin IP 15 mcg, Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 22.5mg | 1 Tablet |
| 2. | Rosuvastatin + Clopidogrel Capsule (Roseday CV 10) | Rosuvastatin Calcium IP eq. to Rosuvastatin (As granules) 10mg, Clopidogrel Bisulphate IP eq. to Clopidogrel (As a film coated tablet) 75mg | 1 Capsule |
| 3. | Rosuvastatin + Clopidogrel Capsule (Roseday CV 10) | Rosuvastatin Calcium IP eq. to Rosuvastatin (As granules) 10mg, Clopidogrel Bisulphate IP eq. to Clopidogrel (As a film coated tablet) 75mg | 1 Capsule |
| 4. | Teneligliptin + Metformin tablet (Ten20 M 1000) | Teneligliptin Hydrobromide hydrate eq. to Teneligliptin 20mg, Metformin HCL 1000mg (as extended release) | 1 Tablet |
| 5. | Clobetasol + Clotrimazole + Neomycin Sulphate Cream | Clobetasol Propionate IP 0.05%w/w, Clotrimazole IP 1.00% w/w, Neomycin Sulphate IP 0.50%w/w | 1 GM |
| 6. | Moxifloxacin + Cefixime Tablets (Moximac Plus) | Moxifloxacin Hydrochloride BP eq. to Moxifloxacin 400mg, Cefixime IP (as trihydrate) eq. to Ahydrous Cefixime 400mg | 1 Tablet |
| 7. | Tramadol + Paracetamol Tablet | Tramadol Hydrochloride IP 37.5mg, Paracetamol IP 325mg | 1 Tablet |
| 8. | Rosuvastatin + Aspirin + lopidogrel Tablet | Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg, Aspirin IP 75mg, Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg | 1 Tablet |
| 9. | Teneligliptin + Metformin Tablet | Teneligliptin Hydrobromide hydrate eq. to Teneligliptin 20mg, Metformin HCL 500mg (as extended release) | 1 Tablet |
| 10. | Teneligliptin + Metformin Tablet | Teneligliptin Hydrobromide hydrate eq. to Teneligliptin 20mg, Metformin HCL 1000mg (as extended release) | 1 Tablet |
| 11. | Paracetamol + Caffeine + Phenylephrine + Diphenhydramine Tablet | Paracetamol IP 500mg, Caffeine (Anhydrous) IP 30mg, Phenylephrine Hydrochloride IP 5mg, Diphenhydramine Hydrochloride IP 25mg | 1 Tablet |
| 12. | Ramipril + Amlodipine Tablet | Ramipril IP 5mg, Amlodipine Besilate IP eq. to Amlodipine 5mg | 1 Tablet |
| 13. | Teneliglitptin + Metformin Tablet | Teneliglitptin Hydrobromide Hydrate 20mg eq. to Tenegliptin 20mg, Metformin Hydrochloride IP 1000mg (In Sustained Release form) | 1 tablet |
| 14. | Teneliglitptin + Metformin Tablet | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin Hydrochloride IP 500mg | 1 Tablet |
| 15. | Rosuvastatin + Clopidogrel Capsule (Roistar CV 10/75) | Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg (As Pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (as Pellets) | 1 Capsule |
| 16. | Rosuvastatin + Clopidogrel Capsule (Roistar CV 20/75) | Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (As Pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (as Pellets) | 1 Capsule |
| 17. | Diclofenac Injection | Diclofenac Sodium IP 75mg Injection | 1 ML |
| 18 | Teneligliptin + Metformin Tablet (EFIGLIN M) | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin HCl 500mg | 1 Tablet |
| 19. | Rosuvastatin + Clopidogrel Capsule | Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (As granules), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (as to film coated tablets) | 1 Capsule |
| 20. | Rosuvastatin + Clopidogrel Capsule (Roseday CV 20) | Rosuvastatin Calcium IP eq. to Rosuvastatin (As Pellets) 20mg, Clopidogrel Bisulphate IP eq. to Clopidogrel (As Pellets ) 75mg | 1 Capsule |
| 21. | Teneligliptin + Metformin Tablet | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin HCL 500mg (as sustained release) | 1 Tablet |
| 22. | Teneligliptin + Metformin Tablet | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin HCL 1000mg (as sustained release) | 1 Tablet |
| 23. | Metformin + Glimepiride + Voglibose Tablet | Metformin HCL 500mg (as sustained release form), Glimepiride 2mg, Voglibose 0.3mg | 1 Tablet |
| 24. | Paracetamol Tablet | Paracetamol IP (as Immediate Release) 300mg, Paracetamol IP (as Sustained Release) 700mg | 1 Tablet |
| 25. | Aceclofenac + Paracetamol Tablet | Aceclofenac IP 100mg, Paracetamol IP 325mg | 1 Tablet |
| 26. | Rosuvastatin + Clopidogrel Capsule | Rosuvastatin 10mg, Clopidogrel 75mg | 1 Capsule |
| 27. | Teneligliptin + Metformin Tablet (EFIGLIN M 1000) | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin Hydrochloride IP 1000mg (as Sustained Release form) | 1 Tablet |
| 28. | Olmesartan + Amlodipine Tablet | Olmesartan Medoxomil IP 20mg, Amlodipine Besylate IP eq. to Amlodipine 5mg, | 1 Tablet |
| 29. | Telmisartan + Metoprolol Tablet (Xstan- Beta 25mg) | Telmisartan IP 40mg, Metoprolol Tartrate IP 25mg (ER) | 1 Tablet |
| 30. | Telmisartan + Metoprolol Tablet (Xstan- Beta 50mg) | Telmisartan IP 40mg, Metoprolol Tartrate IP 50mg (ER) | 1 Tablet |
| 31. | Voglibose + Glimepride + Metformin Tablet | Voglibose IP 0.2mg, Glimepride IP 1mg, Metformin HCL IP 500mg (SR) | 10 Tablets |
| 32. | Atorvastatin + Clopidogrel Capsules (Atchol CV 10mg) | Atorvastatin Calcium eq. to Atorvastatin (as pellets) 10mg, Clopidogrel (as pellets) 75mg. | 10 Capsule |
| 33. | Voglibose + Glimepride + Metformin Tablet | Voglibose IP 0.2mg, Glimepride IP 2mg, Metformin Hydrochloride IP 500mg (SR) | 1 Tablet |
| 34. | Teneligliptin + Metformin Tablet (Tenephron M) | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin Hydrochloride 500mg (SR) | 1 Tablet |
| 35. | Teneligliptin + Metformin Tablet (Tenephron M Forte) | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin HCl 1000mg (SR) | 1 Tablet |
| 36. | Teneligliptin + Metformin Tablet (TYTIN M) | Teneligliptin Hydrobromide hydrate eq. to Teneligliptin 20mg, Metformin Hydrochloride 500mg (as extended release) | 1 Tablet |
| 37. | Tacrolimus Capsule | Tacrolimus IP 0.25mg | 1 Capsule |
| 38. | Telmisartan + Amlodipine Tablet | Telmisartan IP 80mg, Amlodipine Besilate IP 5mg | 10 Tablet |
| 39. | Telmisartan + Amlodipine Tablet (Tigatel AM 40) | Telmisartan IP 40mg, Amlodipine Besylate IP eq. to Amlodipine 5mg | 1 Tablet |
| 40. | Cefixime + Ofloxacin Tablet (Ranixime Plus) | Cefixime Trihydrate eq. to Cefixime Anhydrous IP 200mg, Ofloxacin IP 200mg | 1 Tablet |
| 41. | Teneligliptin + Metformin Tablet (Glypte M) | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin Hydrochloride 500mg | 1 Tablet |
| 42. | Teneligliptin + Metformin Tablet (Glypte M Forte) | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin Hydrochloride 1000mg | 1 Tablet |
| 43. | Glemipiride + Metformin Tablet (Ziglim – M1 Forte) | GlemipirideIP1mg,MetforminHydrochlorde IP 1000mg (as SR form) | 1 Tablet |
| 44. | Glemipiride + Metformin Tablet (Ziglim – M2 Forte) | GlimepirideIP2mg,MetforminHydrochlorde IP 1000mg (as SR form) | 1 tablet |
| 45. | Diclofenac Injection | Diclofenac Sodium IP 75mg/ml | 1 ml |
| 46. | Doxorubicin (Pegylated Liposomal) Injection | Doxorubicin HCL 2mg(Pegylated Liposomal) water for Injection | 1 ml |
| 47. | Telmisartan + Indapamide Tablet | Telmisartan IP 40mg Indapamide IP 1.5mg | 1 Tablet |
| 48. | Paracetamol + Mefenamic Acid Injection (Zydol- P DS) | Paracetamol 250mg Mefenamic Acid 100mg | 1 ml |
| 49. | Paracetamol + Phenylephrine + Chlorpheniramine + Sodium Citrate + Menthol Injection | Each 5ml contains: Paracetamol 125mg Phenylephrine Hydrochloride IP 5mg, Chlorpheniramine Maleate IP 0.5mg, Sodium Citrate IP 60mg, Menthol IP 1mg | 1 ml |
| 50. | Atorvastatin + Clopidogrel Capsule (Atocor CV) | Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As film coated tablet), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As 2 film coated 37.5mg each tablet) | 10 Capsule |
| 51. | Tacrolimus Capsule | Tacrolimus premix (20%) eq. to Tacrolimus IP 0.25mg | 1 capsule |
| 52. | Atorvastatin + Clopidogrel Capsule (Avas 10 Gold) | Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As film coated tablet) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As 2 film coated 37.5mg each tablet) | 10 Capsule |
| 53. | Atorvastatin + Clopidogrel Capsule (Astin 10 Gold) | Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As film coated tablet), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As 2 film coated 37.5mg each tablet) | 10 Capsule |
| 54. | Glimepiride + Metformin Tablet (DIAPRIDE M 0.5) | Glimepiride IP 0.5mg, Metformin Hydrochloride IP 500mg (SR) | 1 Tablet |
| 55. | Telmisartan + Hydrochlorothiazide Tablet (Tigatel H 40) | Telmisartan IP 40mg, Hydrochlorothiazide IP 12.5mg | 1 Tablet |
| 56. | Telmisartan + Hydrochlorothiazide Tablet (Tigatel H 80) | Telmisartan IP 80mg, Hydrochlorothiazide IP 12.5mg | 1 Tablet |
| 57. | Telmisartan + Amlodipine Tablet (Tigatel AMH 40) | Telmisartan IP 40mg, Amlodipine Besylate IP Eq. to Amlodipine 5mg, Hydrochlorothiazide IP 12.5mg | 1 Tablet |
| 58. | Telmisartan + Amlodipine Tablet (Tigatel AMH 80) | Telmisartan IP 80mg, Amlodipine Besylate IP Eq. to Amlodipine 5mg, Hydrochlorothiazide IP 12.5mg | 10 Tablet |
| 59. | Sofosbuvir + Velpatasvir Tablet | Sofosbuvir 400mg, Velpatasvir 100mg | 28 tablets |
| 60. | Methylprednisolone Injection | Methylprednisolone Sodium Succinate USP. Eq. to Methylprednisolone 125mg | 1 Vial |
| 61. | Methylprednisolone Injection | Methylprednisolone Sodium Succinate USP. Eq. to ethylprednisolone 500mg | 1 Vial |
| 62. | Methylprednisolone Injection | Methylprednisolone Sodium Succinate USP. Eq. to Methylprednisolone 1000mg | 1 Vial |
| 63. | Bortezomib Injection (BortiRel) | Bortezomib IP 3.5mg Injection | 1 Vial1 |
Table 2 - Notified Retail price of 1 scheduled formulation of Schedule-I under Drugs (Prices Control) Order, 2013.
| Sl. No. | Name of the Scheduled Formulation | Dosage form & Strength | Unit |
| 1. | Anti-D Immunoglobulin | Injection 150mcg | Each Vial2 |
Table 3 - Notified ceiling price of 1 scheduled formulation of Schedule-I under para 19 of Drugs (Prices Control) Order, 2013.
| Sl. No. | Name of the Scheduled Formulation | Dosage form & Strength | Unit |
| 1. | Phenylephrine | Drops 5% | 1 ML3 |
Form -I application for price fixation of new drug under Para 2(u) of DPCO, 2013
On December 19, 2017, the NPPA has decided to de-link the price approval of new drugs with its internal guidelines. Earlier, in September 2014, the drug pricing regulator had asked all pharmaceutical firms to register themselves under its Integrated Pharmaceutical Database Management System (IPDMS), making this a requirement for fixing and revising drug prices. Now, NPPA in an office memorandum, has said that"price approval not be linked to IPDMS and any other conditionality"28.
NPPA has fixed/revised ceiling prices/Retail Prices of 27 scheduled formulations under DPCO, 2013
On December 20, 2017, the NPPA has fixed/revised the retail prices of 27 scheduled formulations under DPCO, 2013; the formulations with price caps are mostly from anti-diabetics, anti-hypertensive including other antibiotics categories as described below under various provisions –
Table 4 - Notified Retail price of 12 formulations under Drugs (Prices Control) Order, 2013
| S l . No. | Name of the Scheduled Formulation / Brand Name | Strength | Unit |
| 1. | Voglibose + Metformin | Voglibose 0.2mg Metformin 500mg | 1 Tablet |
| 2. | Voglibose + Metformin | Voglibose 0.3mg Metformin 500mg | 1 Tablet |
| 3. | Voglibose + Metformin + Glimepirid | Voglibose 0.2mg Metformin 500mg Glimepirid 1mg | 1 Tablet |
| 4. | Voglibose + Metformin + Glimepirid | Voglibose 0.2mg Metformin 500mg Glimepirid 1mg | 1 Tablet |
| 5. | Voglibose + Metformin + Glimepirid | Voglibose 0.2mg Metformin 500mg Glimepirid 1mg | 1 Tablet |
| 6. | Voglibose + Metformin + Glimepirid | Voglibose 0.2mg Metformin 500mg Glimepirid 2mg | 1 Tablet |
| 7. | Voglibose + Metformin + Glimepirid | Voglibose 0.2mg Metformin 500mg Glimepirid 2mg | 1 Tablet |
| 8. | Voglibose + Metformin + Glimepirid | Voglibose 0.2mg Metformin 500mg Glimepirid 2mg | 1 Tablet |
| 9. | Voglibose + Metformin + Glimepirid | Voglibose 0.3mg Metformin 500mg Glimepirid 1mg | 1 Tablet |
| 10. | Voglibose + Metformin + Glimepirid | Voglibose 0.3mg Metformin 500mg Glimepirid 1mg | 1 Tablet |
| 11. | Voglibose + Metformin + Glimepirid | Voglibose 0.3mg Metformin 500mg Glimepirid 2mg | 1 Tablet |
| 12. | Diclofenac + Tramadol | Diclofenac 75mg Tramadol 50mg | 1 Tablet4 |
Table 5 - Notified Retail Price of 15 formulations under Drugs (Prices Control) Order, 2013
| S l . No. | Name of the Scheduled Formulation / Brand Name | Strength | Unit |
| 1. | Glimepiride + Metformin Tablets | Glimepiride 1mg & Metformin 500mg. | 1 tablet |
| 2. | Glimepiride + Metformin Tablets | Glimepiride 2mg & Metformin 500mg. | 1 Tablet |
| 3. | Metoprolol + Chlorthalidone Tablets | Metoprolol 25mg & Chlorthalidone 12.5mg. | 1 Tablet |
| 4. | Metoprolol + Chlorthalidone Tablets | Metoprolol 25mg & Chlorthalidone 12.5mg | 1 Tablet |
| 5. | Metoprolol + Chlorthalidone Tablets | Metoprolol 50mg & Chlorthalidone 12.5mg | 1 Tablet |
| 6. | Metoprolol + Chlorthalidone Tablets | Metoprolol 50mg & Chlorthalidone 12.5mg | 1 Tablet |
| 7. | Moxifloxacin + Cefixime Tablets | Moxifloxacin 400mg & Cefixime 400mg | 1 Tablet |
| 8. | Gliclazide + Pioglitazone + Metformin Tab- lets | Gliclazide 60mg, Pioglitazone 7.5mg & Metformin 500mg | 1 Tablet |
| 9. | Teneligliptin + Metformin Tablets | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg, Metformin HCl 1000mg | 1 Tablet |
| 10. | Teneligliptin + Metformin Tablets | Teneligliptin Hydrobromide Hydrate eq. to Teneligliptin 20mg Metformin HCl 500mg | 1 Tablet |
| 11. | Glimepiride + Metformin Tablets | Glimepiride 1mg & Metformin 1000mg | 1 Tablet |
| 12. | Glimepiride + Metformin Tablets | Glimepiride 2mg & Metformin 1000mg. | 1 Tablet |
| 13. | Glimepiride + Metformin Tablets | Glimepiride 3mg & Metformin 1000mg | 1 Tablet |
| 14. | Metformin + Glimepiride + Pioglitazone Tablets | Metformin 500mg, Glimepiride 1mg & Pioglitazone 15mg | 1 Tablet |
| 15. | Metformin + Glimepiride + Pioglitazone Tablets | Metformin 500mg, Glimepiride 2mg & Pioglitazone 15mg | 1 Tablet5 |
NPPA's consideration of Medtronic's request for discontinuation of Endeavour Sprint RX Zotarolimus Eluting Coronary Stent System
On December 27, 2017, the NPPA has considered the request of M/s India Medtronic Pvt. Ltd for discontinuation of Endeavor Sprint RX Zotarolimus Eluting Coronary Stent based on unavailability because of stoppage of its production globally; and noted in the Authority meeting No 51 held on 15/12/2017. The consideration was under para 21(2) of Drugs Prices Control Order (DPCO), 2013 on the ground of stoppage of manufacturing of these stent brands globally.
Para 21 (2) of the DPCO, 2013 reads as follows:
21. Monitoring the availability of scheduled formulations:
(1)...
(2) Any manufacturer of scheduled formulation, intending to discontinue any scheduled formulation from the market shall issue a public notice and also intimate the government in Form- IV of Schedule-ll of this order in this regard at least six months prior to the indented date of discontinuation and the Government may, in public interest, direct the manufacturer of the scheduled formulation to continue with required level of production or import for the period not exceeding one year, from the intended date of such discontinuation within a period of sixty days of receipt of such intimation
NPPA has further advised that, in order to formally 'complete' the process of 'withdrawal' the company will issue a public notice in the prescribed format, in at least two national newspapers (one English and one in Hindi) and also publish the same on their website and send a copy of the same to NPPA29.
Footnotes
27 http://www.nppaindia.nic.in/order/om_07-12-2017.pdf
28 http://www.nppaindia.nic.in/order/om_19-12-2017.pdf
29 http://www.nppaindia.nic.in/order/om_27-12-2017.pdf
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
